Tandem Diabetes Care (TNDM) Other Gross PP&E Adjustments (2016 - 2025)
Tandem Diabetes Care (TNDM) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with -$98.4 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments fell 12.55% year-over-year to -$98.4 million, compared with a TTM value of -$98.4 million through Sep 2025, down 12.55%, and an annual FY2024 reading of $55.7 million, up 34.0% over the prior year.
- Other Gross PP&E Adjustments was -$98.4 million for Q3 2025 at Tandem Diabetes Care, roughly flat from -$98.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $72.1 million in Q4 2021 and bottomed at -$126.7 million in Q2 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$57.4 million, with a median of -$88.3 million recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 1249.23% in 2021, then soared 194.62% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at $72.1 million in 2021, then tumbled by 80.43% to $14.1 million in 2022, then skyrocketed by 194.62% to $41.5 million in 2023, then skyrocketed by 34.0% to $55.7 million in 2024, then plummeted by 276.68% to -$98.4 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for TNDM at -$98.4 million in Q3 2025, -$98.4 million in Q2 2025, and -$101.0 million in Q1 2025.